Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1

Annals of Internal Medicine

Volumn 124, Issue 8, 1996, Pages 757-762

  Thea, Donald M ^a   Porat, Reuven ^a   Nagimbi, Khondi ^d   Baangi, Matela ^d   St Louis, Michael E ^b   Kaplan, Gilla ^c   Dinarello, Charles A ^a   Keusch, Gerald T ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d Rockefeller University ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CAROTENE; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DEMOCRATIC REPUBLIC CONGO; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYMPTOM;

EID: 0029873335     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-8-199604150-00009     Document Type: Article

References (40)

1. Serwadda D, Mugerwa RD, Sewankambo NK, Lwegaba A, Carswell JW, Kirya GB, et al. Slim disease, a new disease in Uganda and its association with HTLV-III infection. Lancet. 1985,2.849-52.
2. Vassalli P. The pathophysiology of tumor necrosis factors Annu Rev Immunol 1992;10.411-52
3. Dinarello CA. Interleukin-1 and interleukin-1 antagonism Blood 1991,77 1627-52
4. Lowry SF. Cytokine mediators of immunity and inflammation Arch Surg 1993;128.1235-41.
5. Okamoto T, Matsuyama T, Mori S, Hamamoto Y, Kobayashi N, Yamamoto N, et al. Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha AIDS Res Hum Retroviruses. 1989,5 131-8
6. Poli G, Kinter AL, Fauci AS. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist Proc Natl Acad Sci U S A 1994,91 108-12
7. Rambaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR, et al. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991,78:3248-53.
8. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 1992,89:4845-9
9. Godfried MH, van der Poll T, Weverling GJ, Mulder JW, Jansen J, van Deventer SJ, et al. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis. 1994;169 739-45
10. Godfried MH, van der Poll T, Jansen J, Romijin JA, Schattenkerk JK, Endert E, et al. Soluble receptors for tumour necrosis factor a putative marker of disease progression in HIV infection AIDS 1993;7 33-6
11. Ryder RW, Nsa W, Hassig SE, Behets F, Rayfield M, Ekungola B, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989,320:1637-42.
12. St. Louis ME, Kamenga M, Brown C, Nelson AM, Manzila T, Batter V, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269.2853-9
13. Interpretation and use of western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections MMWR Morb Mort Wkly Rep 1989;38(Suppl7) 1-7
14. Van Der Meer JW, Endres S, Lonnemann G, Cannon JG, Ikejima T, Okusawa S, et al. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol 1988,43:216-23.
15. Shapiro L, Clark BD, Omecole SF, Poutsiaka DD, Granowitz EV, Dinarello CA. Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J Infect Dis 1993,167 1344-50
16. Lisi PJ, Chu CW, Koch GA, Endres S, Lonnemann G, Dinarello CA. Development and use of a radioimmunoassay for human interleukin-1 beta. Lymphokine Res 1987,6 229-44
17. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood. 1991,78.1275-81.
18. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF Blood 1990,75:40-7
19. Porat R, Poutsiaka DD, Miller LC, Granowitz EV, Dinarello CA. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells FASEB J 1992;6:2482-6
20. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever J Infect Dis 1990;161 79-84
21. Cannon JG, Friedberg JS, Gelfand JA, Tompkins RG, Burke JF, Dinarello CA. Circulating interleukin-1β and tumor necrosis factor-α concentrations after burn injury in humans. Crit Care Med 1992,20.1414-9
22. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease Nature 1993,362 355-8
23. Kauffman CA, Jones PG, Kluger MJ. Fever and malnutrition endogenous pyrogen/interleukin-1 in malnourished patients Am J Clin Nutr 1986,44.449-52
24. Reka S, Garro ML, Kotler DP. Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection Lymphokine Cytokine Res. 1994,13.391-8
25. Roux-Lombard P, Modoux C, Cruchaud A, Dayer JM. Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1 Clin Immunol Immunopathol 1989,50.374-84
26. Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, et al. Infection with HIV is associated with elevated IL-6 levels and production J Immunol 1990,144 480-4
27. Rautonen J, Rautonen N, Martin NL, Philip R, Wara DW. Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-α and immunoglobulin G and A concentrations in children with HIV infection. AIDS 1991,5 1319-25
28. Molina JM, Schindler R, Ferriani R, Sakaguchi M, Vannier E, Dinarello CA, et al. Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1). J Infect Dis. 1990,161.888-93
29. Kikuta H, Nakane A, Lu H, Taguchi Y, Minagawa T, Matsumoto S. Interferon induction by human herpesvirus 6 in human mononuclear cells. J Infect Dis 1990,162 35-8
30. von Sydow M, Sonnerborg AB, Gaines H, Strannegaard O. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 1991,7:375-80
31. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, et al. Production of interleukin-1-receptor antagonist during experimental endotoxaemia Lancet 1991;338 1423-4.
32. Bargetzi MJ, Lantz M, Smith CG, Torti FM, Olsson I, Eisenberg SP, et al. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res 1993,53.4010-3.
33. Granowitz EV, Clark BD, Vannier E, Callahan MV, Dinarella CA. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 1992,79 2356-63
34. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors J Exp Med 1992;175-323-9
35. Scott-Algara D, Vuillier F, Marasescu M, de Saint Martin J, Dighiero G. Serum levels of IL-2, IL-1α, TNF-α, and soluble receptor of IL-2 in HIV-1 infected patients AIDS Res Hum Retroviruses 1991,7 381-6.
36. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis Lancet. 1993,341.146-8
37. Girardin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, Dayer JM, et al. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia The J5 Study Group Immunology 1992,76:20-3
38. Ferreta M, Casini-Raggi V, Pizarro TT, Eisenberg SP, Nast CC, Cominelli F. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis J Clin Invest 1994,94:449-53
39. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992,327 329-37
40. Suttmann U, Selberg O, Gallati H, Ockenga J, Deicher H, Muller MJ. Tumor necrosis factor receptor levels are linked to the acute-phase response and malnutrition in human-immunodeficiency-virus-infected patients Clin Sci (Colch) 1994,86 461